Cagrilintide is a synthetic, long-acting analog of amylin, a hormone released alongside insulin that helps slow digestion, control appetite and regulate blood sugar. Its structural modifications make it more stable than natural amylin, allowing once-weekly dosing. It binds amylin and calcitonin receptors and is being studied for weight management and glycemic control, both on its own and together with GLP-1 agonists.

This compound is supplied strictly for laboratory research purposes and is not intended for human or veterinary use, diagnosis, or treatment. Tested in the United States 🇺🇸 ++